Amyotrophic Lateral Sclerosis
Conditions
Keywords
Amyotrophic Lateral Sclerosis, Bulbar disfunction, Rik factors ALS
Brief summary
Amyotrophic Lateral Sclerosis (ALS) is a degenerative neuromuscular disease, progressing inexorably to respiratory failure, the by involvement of respiratory muscles, the commitment with most impact on the prognosis of ALS. According to current knowledge, the clinical presentation of the disease is characterized by spinal or bulbar involvement, the latter being associated with a worse prognosis. There are multiple factors described in the aetiology of ALS, as the successive damage the motor neuron, which can happen in high-impact athletes, or exposure to heavy metals. Genetic mutations are also described, being associated to a higher prevalence of ALS. Data from retrospective studies with ALS populations reveal a prevalence of 4-8 cases per 100,000 persons. Research carried out in Trás-os-Montes e Alto Douro region (Northeast of Portugal) shows a high prevalence of ALS, with near 10 cases per 100,000 persons, with a recent increase in the bulbar involvement. The reasons for the high prevalence of ALS in this region are unknown.
Detailed description
The objective of this research is to pursue potentially involved genetic mutations in this disease (new or previously described), in addition to carry out a epidemiological questionnaire including data on personal history, environmental and occupational exposure that might be underlying this high prevalence.
Interventions
Genetic findings in ALS patients
Epidemiological characterization in ALS patients
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with Amyotrophic Lateral Sclerosis sent to a medical consultation
Exclusion criteria
* Amyotrophic Lateral Sclerosis not confirmed * Ages less than 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Finding environmental risk factor | 2 years | Apply epidemiogycal form to All ALS patients sentido to respiratory evaluation in 2 years. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Regional prevalence | 1 year | Identify All cases ALS in regional area ( in north of Portugal) |
| Finding a genetic marker | 2 years | Scan all ALS patients to eventually finding new ALS genes |
Countries
Portugal